UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 THIRD QUARTER FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
Universal Health Services (UHS) PT Raised to $227 at Cantor Fitzgerald
October 28, 2024 6:38 AM EDTCantor Fitzgerald analyst Sarah James raised the price target on Universal Health Services (NYSE: UHS) to $227.00 (from $219.00) while maintaining a Neutral rating.
The analyst comments "We are raising our 12-month price target to $227 from $219. Our 7.9x '26E EV/EBITDA reflects... More
Universal Health Services (UHS) PT Lowered to $211 at RBC Capital
October 28, 2024 6:31 AM EDTRBC Capital analyst Frank Morgan lowered the price target on Universal Health Services (NYSE: UHS) to $211.00 (from $222.00) while maintaining a Sector Perform rating.
The analyst comments "UHS stock traded off ~10% Friday on elevated buyside expectations with several investors pointing to softer... More
Deutsche Bank Reiterates Buy Rating on Universal Health Services (UHS)
October 28, 2024 5:56 AM EDTDeutsche Bank analyst Pito Chickering reiterated a Buy rating and $240.00 price target on Universal Health Services (NYSE: UHS)
The analyst comments "Net-net. While the election may be an overhang over the next couple of weeks, especially given Trumps position on exchange subsidies; ultimately, we dont believe UHS deserves to be down almost 10% today. The 3Q performance and lack of an increase to guidance wasnt enough to support the stock... More
